Abstract
Despite numerous potential health outcomes of dog guardianship, their value has not been examined in the HIV-positive population. The study objective was to examine the relationship between dog guardianship and HIV clinical outcomes (antiretroviral adherence [≥95% versus <95%], HIV viral load [≥48 versus <48 copies/mL], and CD4 count) among HIV-positive individuals. The authors conducted a secondary analysis of baseline data of 370 HIV-positive men on antiretroviral regimen enrolled in the Duo Project. Generalized estimating equations were used for inferential regression analyses, while controlling for the focal dog guardianship variable and nonfocal covariates. Current dog guardianship was reported in 28.7% of participants. Dog guardianship may be associated with higher CD4 (coefficient = 60.6, P = .052) and adherence ≥95% (odds ratio [OR] = 1.80, P = .048); however, having a detectable viral load was not related to dog guardianship (OR = 0.94, P = .85). Further clinical research with detailed dog guardianship data is needed to further examine the association between dog guardianship and HIV clinical outcomes.
Introduction
Animal guardianship is an integral part of life in the United States, with 39% of households claiming at least 1 dog, which is equivalent to approximately 78.2 million dogs. 1 Pet companionship, particularly dog guardianship, has been associated with numerous health behaviors and outcomes, including greater exercise duration and frequency 2 –7 ; higher capacity to carry out activities of daily living 8 ; decreased blood pressure and heart rate 9 –11 ; lower triglycerides 12,13 ; improved survival postmyocardial infarction 14,15 ; and reduced anxiety, stress, 16 –18 depressive symptoms, 19,20 and other symptoms associated with psychiatric disorders and diseases. 21 –23 Additionally, there are data regarding the potential benefits of dogs in programs in incarcerated populations, 24 reduction of depression and increased arterial oxygen saturation in those undergoing chemotherapy, 25 and improved clinical outcomes and decreased hospital stay in patients with heart failure. 26,27
HIV-positive individuals have increased risk of hypertension, hyperlipidemia, and cardiovascular events, 28,29 which can lead to higher pill burden and increased likelihood of drug–drug interactions and adverse effects, which in turn may result in nonadherence to antiretroviral therapy (ART). 30,31 Additionally, depression and stress are independent barriers to ART adherence. 32,33 Despite their potential benefits and ubiquitous nature, the value of dog guardianship has not been examined in the HIV-positive population. Therefore, the objective of this study was to examine the correlation between dog guardianship and HIV clinical outcomes, such as adherence to ART, HIV viral load, and CD4 count, among HIV-positive individuals.
Methods
The authors conducted a secondary analysis of baseline data of HIV-positive men on ART enrolled in the Duo Project, a longitudinal study of how relationship dynamics among men who have sex with men can influence ART adherence. 34,35
Participants included in this secondary data analysis were men who were ≥18 years of age, had been in a primary relationship with another man for ≥3 months, were HIV positive, and had been taking ART regimen for at least 30 days. Participants for the Duo Project were recruited from the San Francisco Bay Area using referrals from other participants and passive recruitment through advertisement. The University of California, San Francisco Committee on Human Research granted approval for this research, and the participants signed an informed consent form prior to study initiation.
Data were collected using audio computer-assisted self-interviewing (ACASI). The authors inquired about the participant’s dog guardianship (yes versus no). Adherence to ART was assessed by self-report using the visual analog scale, which estimates 30-day adherence to ART on a scale of 0% to 100%. 36 Demographics (age, race/ethnicity, education, income, and employment), ever homeless, relationship length, depression (assessed using the Center for Epidemiologic Studies Depression [CES-D] scale), substance use (crack, cocaine, heroin, street methadone, and other stimulants) in the past 3 months, length of time since HIV diagnosis, ART regimen, and HIV clinical parameters (CD4 count, and HIV viral load) were also included. The viral load test was performed using the COBAS AmpliPrep/COBAS TaqMan HIV test kit (Roche Molecular Diagnostics, Pleasanton, California), which has a quantification limit of 48 copies/mL.
The authors used descriptive statistics to generate frequencies, means, and standard deviations (SDs). Using bivariable regression, the authors examined the associations between the 3 key HIV outcome variables (ART adherence [dichotomized as ≥95% versus <95%], CD4 count, and HIV viral load [dichotomized as ≥48 versus <48 copies/mL]); focal covariate (dog guardianship); and hypothesized confounders (age, race/ethnicity, education, yearly income, employment status, ever homeless, substance use, relationship length, and depression).
To account for clustering of individuals within couples, generalized estimating equations (GEEs) with an exchangeable correlation structure and robust standard errors were used for inferential regression analyses. 37 Multivariable regression models corresponding to the 3 HIV outcome variables were fitted including the focal dog guardianship independent variable and other nonfocal covariates where the bivariable P value was less than .25. 38 Nonfocal covariates were removed using backward elimination, until all remaining nonfocal covariates were significant at P < .05. All analyses were conducted using Stata, version 12.1 (StataCorp, College Station, Texas).
Results
Data from 370 HIV-positive men on ART were analyzed; see Table 1 for sample characteristics. Mean length of time since HIV diagnosis was 160.5 months (SD = 96.5). Approximately 73% of individuals reported adherence ≥95%, 76.5%, had an undetectable viral load (N = 366), and mean CD4 count was 564 cells/mm3 (SD = 260.8; N = 366). Forty-six percent reported taking protease inhibitor (PI)-based ART regimens, 41% reported taking nonnucleoside reverse transcriptase inhibitor (NNRTI)-based regimens, and 13% reported combined PI/NNRTI-based regimens or other. Current dog guardianship was reported in 28.7% of participants.
Univariable Analysis and Bivariable Regression Models of Hypothesized Correlates of ART Regimen Adherence, CD4 Count, and HIV Viral Load.
Abbreviations: OR, odds ratio; CI, confidence interval; Ref, reference; B, unstandardized linear regression coefficient representing mean change in outcome per unit change in the independent variable; CES-D, Center for Epidemiologic Studies Depression; SD, standard deviation.
a Depression score based on CES-D.
b Substance use: street methadone, crack, cocaine, heroin, and stimulants.
c Omnibus Wald test.
Table 1 includes the correlates of ART regimen adherence, viral load, and CD4 count in bivariable analyses. Variables with a P value < .25 are in boldface and were examined in multivariable regression models. In the final multivariable model with adherence as the outcome, reported dog guardianship (odds ratio [OR] = 1.80; 95% confidence interval [CI] = 1.00-3.24; P = .048) and substance use (OR = 0.46; 95% CI = 0.28-0.76; P = .002) were statistically significant. In the final CD4 count multivariable model, dog guardianship was marginally significant (coefficient = 60.6; 95% CI = −0.62 to 121.8; P = .052) and race (P = .01) and having ever been homeless (B
Discussion
Our findings supply preliminary evidence that dog guardianship may be associated with higher CD4 count and higher ART regimen adherence. However, having a detectable HIV viral load was not related to dog guardianship, which may have been due to the fact that most participants had an undetectable viral load. Alternatively, the finding could represent a true lack of association. Further research with primary collection of more extensive dog guardianship data is needed to cast further light on this and other relevant links between dog guardianship and HIV clinical outcomes.
In general, the mechanisms underlying the correlation between dog guardianship and improved physical and psychological health are not well understood. There are potentially indirect relationships related to an increase in the number of and duration of recreational activities and walks 3 –7,39 –41 as well as an enhanced social interaction and contact with other people 42 –45 and alleviation of the feelings of loneliness. 46 The potential impact of pet guardianship on increased social support and decreased loneliness has been examined in 2 prior studies of HIV-positive individuals. 19,47 A theorized direct effect of contact with animals on improved well-being may result from the presence or the observation of animals reducing physiological and psychological response to stress and anxiety, which may yield decreased blood pressure and heart rate. 11,17,48 The role of neuropeptides in the mechanism underlying human–dog bonding have also been explored, with a significant increase in oxytocin, prolactin, phenylacetic acid, and dopamine levels in humans and dogs and a decrease in cortisol in human beings observed. 49 –51
While the role of neuropeptides or the stress- and anxiety-reducing effect of dog guardianship, leading to fewer comorbidities are possible explanations for the results of our study, the authors hypothesize several other possible mechanisms for these associations. The first potential mechanism is related to the role of organization and routinization. Individuals caring for a dog likely maintain organized schedules that include daily recreational walks and feedings, based on the needs of the dog. The beneficial role of organization and ART regimen adherence has been examined in prior research 52 ; routines associated with caring for a dog may similarly promote a higher level of adherence. Conversely, dog guardianship may be a proxy for other factors. For example, it is possible that individuals who are more organized, have more housing stability, have less psychosocial distress, and are overall more likely to have higher adherence, are also more likely to have the capability and inclination to care for a dog.
Another hypothesized mechanism involves a sense of responsibility. Caring for a dog means taking care of another dependent being; this may translate to better self-care in order to maintain a level of health that can enable a person to take care of that being. This responsibility may motivate an individual to have a high degree of medication adherence, start ART earlier, and participate in other activities that may result in a stronger immune system.
A limitation of the study includes the cross-sectional approach with which causal order cannot be established. Additionally, a drawback of self-reported medication adherence data is that respondents tend to overreport this value. Therefore, despite the relative ease of collection, these data are less objective and may be less reliable than other methods, such as pharmacy refill records or electronic drug monitors. Lastly, the couples-focus and location of the parent study indicates that the results can only be generalized to gay male couples living in San Francisco; therefore, the authors view this study as exploratory and believe that future research should examine these results in a larger and more generalizable population, with more objective measures of adherence and more extensive measures of dog guardianship and dog-related behaviors (eg, mean time spent with the dog per day).
The authors believe that the results warrant a closer examination and larger studies that can discern the directionality of cause and effect need to be conducted. Future research that may support and further expand and justify the results may provide an incentive to promote dog adoption for appropriate individuals, support dog companionship programs, and promote evidence-based updates to regulations governing requirements for dog guardianship in housing units to render such regulations more pet-friendly while still satisfying regulatory goals.
Footnotes
Acknowledgment
The authors would like to thank Albaloo, Penny, and Gus.
Authors’ Note
The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Declaration of Conflicting Interests
The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Funding
The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This project was supported by NIH award numbers K23MH097649, K24MH087220, and R01NR010187.
